On September 28, the Board of Directors of China Biologic Products, Inc. appointed Charles (Le) Zhang as a director of the company, effective from October 1, 2012. Mr. Charles Zhang has served as a Partner of DT Capital Partners since 2008. Mr. Zhang also served as a Senior Associate at Goldman Sachs Gao Hua Securities from 2006 to 2008, a senior manager at Huwei Technologies from 2000 to 2004 and a product manager at Alcatel from 1998 to 2000.
China Biologic Products Holdings, Inc.
Equities
CBPO
KYG215151047
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.58% | 115B | |
+12.41% | 107B | |
-3.55% | 21.6B | |
-12.38% | 22.31B | |
-6.91% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |